IP Library Granted Patent US 8,440,687
Granted Patent B2
US 8,440,687 · App. 13/426,521 · Granted May 14, 2013

Oligomer-opioid agonist conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,687
App. No.
13/426,521
Granted
May 14, 2013
Kind
B2
Abstract

The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Claims (20)

1. An opioid agonist compound selected from the formula

wherein n is an integer from 1 to 15; and pharmaceutically acceptable salts thereof.

2. The opioid agonist compound of claim 1 , wherein n is an integer from 1 to 10.

3. The compound of claim 1 , wherein n is 1.

4. The compound of claim 1 , wherein n is 2.

5. The compound of claim 1 , wherein n is 3.

6. The compound of claim 1 , wherein n is 4.

7. The compound of claim 1 , wherein n is 5.

8. The compound of claim 1 , wherein n is 6.

9. The compound of claim 1 , wherein n is 7.

10. The compound of claim 1 , wherein n is 8.

11. The compound of claim 1 , wherein n is 9.

12. The compound of claim 1 , wherein the pharmaceutically acceptable salt is the HCl (hydrochloric acid) salt.

13. The compound of claim 1 , wherein the pharmaceutically acceptable salt is the TFA (triflouroacetic acid) salt.

14. A composition comprising a compound of claim 1 , and optionally, a pharmaceutically acceptable excipient.

15. The composition of claim 14 , wherein the composition is suitable for oral administration.

16. A composition of matter comprising a compound of claim 1 , wherein the compound is present in a dosage form.

17. A method of treating pain in a patient, comprising administering a therapeutically effective amount of a compound of claim 1 to the patient in need thereof.

18. A method of treating pain in a patient, comprising administering the composition of claim 14 to the patient in need thereof.

19. The compound of claim 1 , wherein the pharmaceutically acceptable salts are selected from a hydrochloric acid salt, a hydrobromic acid salt, a hydroiodic acid salt, a sulfuric acid salt, a phosphoric acid salt, a p-toluenesulfonic acid salt, a methanesulfonic acid salt, an oxalic acid salt, a p-bromophenyl-sulfonic acid salt, a carbonic acid salt, a succinic acid salt, a citric acid salt, a benzoic acid salt, and an acetic acid salt.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2023
From: INHERIS BIOPHARMA, INC.
To: NEKTAR THERAPEUTICS
Reel/Frame 062313/0501 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: INHERIS BIOPHARMA, INC.
Reel/Frame 052435/0062 →
CHANGE OF NAME Recorded Nov 15, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: INHERIS BIOPHARMA, INC.
Reel/Frame 051038/0585 →
SECURITY INTEREST Recorded Oct 28, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 050846/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: NEKTAR THERAPEUTICS
To: INHERIS PHARMACEUTICALS, INC.
Reel/Frame 050846/0461 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2012
From: RIGGS-SAUTHIER, JENNIFER; DENG, BO-LIANG; RILEY, TIMOTHY A.
To: NEKTAR THERAPEUTICS
Reel/Frame 029480/0519 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →